A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Clinical trial NCT05348876 · RECRUITING
Trial details
- NCT number
- NCT05348876
- Sponsor
- Bayer
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2027-04-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.